Jun‐Eul Hwang
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Inflammatory Biomarkers in Disease Prognosis
- Otorhinolaryngology top 5%
- Head and Neck Cancer Studies
Papers in
- Oncology 47
- Colorectal Cancer Treatments and Studies 9
- Cancer Immunotherapy and Biomarkers 8
-
- Gastrointestinal Tumor Research and Treatment 9
- Co-authors
- Sang‐Hee ChoIk‐Joo ChungHyun‐Jeong ShimWoo Kyun BaeWoo‐Kyun BaeEu Chang HwangHyun Jeong ShimDae‐Eun Kim
- Journals
- Journal of Clinical Oncology (8 papers)BMC Cancer (6 papers)Cancer Research and Treatment (6 papers)Journal of Korean Medical Science (5 papers)Cancer Chemotherapy and Pharmacology (4 papers)
- Partner nations
- South KoreaUnited StatesUnited Kingdom
In The Last Decade
Jun‐Eul Hwang
100 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 103
- Oncology 663
- Otorhinolaryngology 92
- Hepatology 144
- Cancer Research 262
- Pulmonary and Respiratory Medicine 477
Countries citing papers authored by Jun‐Eul Hwang
This map shows the geographic impact of Jun‐Eul Hwang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun‐Eul Hwang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun‐Eul Hwang more than expected).
Fields of papers citing papers by Jun‐Eul Hwang
This network shows the impact of papers produced by Jun‐Eul Hwang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun‐Eul Hwang. The network helps show where Jun‐Eul Hwang may publish in the future.
Co-authors
The 25 scholars most cited alongside Jun‐Eul Hwang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2022 | 8 | |
| 4 | 2022 | 5 | |
| 5 | 2021 | 10 | |
| 6 | 2020 | 34 | |
| 7 | 2020 | 31 | |
| 8 | 2020 | 8 | |
| 9 | 2018 | 14 | |
| 10 | 2017 | 15 | |
| 11 | 2016 | 24 | |
| 12 | 2015 | 24 | |
| 13 | 2014 | 28 | |
| 14 | 2013 | 17 | |
| 15 | 2013 | 50 | |
| 16 | Two Cases of Neuroendocrine Carcinoma and GIST in a Patient with Neurofibromatosis Type 1 | 2011 | 0 |
| 17 | Survival Prediction in Terminally Ill Cancer Patients: Laboratory Variables and Prospective Validation of The Palliative Prognostic Index | 2011 | 3 |
| 18 | 2010 | 10 | |
| 19 | A Case of Primary Pancreatic Lymphoma That Manifested with Acute Pancreatitis and Obstructive Jaundice | 2009 | 1 |
| 20 | A case of gastric hepatoid adenocarcinoma misdiagnosed as an extragonadal germ cell tumor | 2007 | 1 |
About Jun‐Eul Hwang
Jun‐Eul Hwang is a scholar working on Oncology, Gastroenterology, Otorhinolaryngology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 108 papers that have together received 1.8k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (16 papers), Gastrointestinal Tumor Research and Treatment (9 papers), Colorectal Cancer Treatments and Studies (9 papers), Cancer Immunotherapy and Biomarkers (8 papers), Esophageal Cancer Research and Treatment (8 papers), Bladder and Urothelial Cancer Treatments (8 papers), Metastasis and carcinoma case studies (7 papers) and Urinary and Genital Oncology Studies (7 papers). The work is most often cited by research in Oncology (663 citations), Otorhinolaryngology (92 citations), Hepatology (144 citations), Cancer Research (262 citations) and Pulmonary and Respiratory Medicine (477 citations). Jun‐Eul Hwang has collaborated with scholars based in South Korea, United States and United Kingdom. Frequent co-authors include Sang‐Hee Cho, Ik‐Joo Chung, Hyun‐Jeong Shim, Woo Kyun Bae, Woo‐Kyun Bae, Eu Chang Hwang, Hyun Jeong Shim, Dae‐Eun Kim, Ik‐Joo Chung and Ji Hee Lee. Their work appears in journals such as Journal of Clinical Oncology, BMC Cancer, Cancer Research and Treatment, Journal of Korean Medical Science and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.